Fatty acid binding protein 3 as a potential mediator for diabetic nephropathy in eNOS deficient mouse

Shota Ozawa1, Shuko Ueda2, Ying Li3

  • 1TMK Project, Medical Innovation Center, Kyoto University, Kyoto, Japan; Pharmacology Research Laboratories II, Mitsubishi Tanabe Pharma Corporation, Saitama, Japan.

Insights

Fatty acid binding protein 3 (FABP3) is induced in kidney cells during diabetic nephropathy, promoting inflammation and injury. This suggests FABP3 plays a key role in the development of diabetic kidney disease.

Area of Science:

  • Nephrology
  • Metabolic Diseases
  • Molecular Biology

Background:

  • Diabetic nephropathy involves glomerular injury linked to abnormal lipid metabolism.
  • Fatty acid binding proteins (FABPs) are crucial regulators of lipid metabolism.
  • The precise role of FABPs in diabetic kidney disease pathogenesis is unclear.

Purpose of the Study:

  • To investigate the role of FABP in mediating glomerular injury in a diabetic mouse model.
  • To identify specific FABP isoforms involved in diabetic nephropathy.

Main Methods:

  • Utilized a diabetic endothelial nitric oxide synthase knockout (eNOS KO) mouse model.
  • Performed microarray analysis on isolated glomeruli.
  • Investigated FABP3 expression and function in rat mesangial cells.

Main Results:

  • Glomerular injury in diabetic eNOS KO mice correlated with inflammation, macrophage infiltration, and MCP-1 induction.
  • FABP3 mRNA was significantly upregulated in glomeruli of diabetic eNOS KO mice.
  • Overexpression of FABP3 enhanced palmitate-induced MCP-1 production in mesangial cells.

Conclusions:

  • FABP3 is upregulated in mesangial cells within the diabetic kidney.
  • FABP3 likely mediates inflammatory responses, specifically MCP-1 induction, contributing to diabetic nephropathy.